The guideline, Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation, focuses on the technology, a summary of the Appraisal Committee’s key conclusions, and implementation of edoxaban.
This site is intended for health professionals only
The guideline, Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation, focuses on the technology, a summary of the Appraisal Committee’s key conclusions, and implementation of edoxaban.
See how our symptom tool can help you make better sense of patient presentations
Click here to search a symptom
IMPORTANT LINKS
MORE FROM COGORA
© Cogora 2025
Cogora Limited. 1 Giltspur Street, London EC1A 9DD
Registered in the United Kingdom. Reg. No. 2147432
